Corpus Intelligence IC Memo — EATON RAPIDS MEDICAL CENTER 2026-04-26 21:28 UTC
IC Memo — EATON RAPIDS MEDICAL CENTER
Investment Committee Memorandum | MI | 20 beds | Grade C | EBITDA uplift $2.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

EATON RAPIDS MEDICAL CENTER

CCN 231324 | EATON, MI | 20 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

EATON RAPIDS MEDICAL CENTER is a 20-bed suburban community hospital in EATON, MI with $34.8M in net patient revenue and a -4.0% operating margin. The hospital serves a payer mix of 29.7% Medicare, 1.1% Medicaid, and 69.1% commercial.

Thesis: Turnaround. Our ML models identify $2.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.0% to 3.3% (+736bps).

Net Revenue HCRIS$34.8M
Current EBITDA COMPUTED$-1.4M
Operating Margin COMPUTED-4.0%
Occupancy HCRIS19.4%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS60.5%
Distress Probability ML56.9%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
52
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -4.0% places it above the state median. Among 52 size-comparable peers (10-40 beds), the median margin is 0.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-40), prioritizing same-state peers. 52 hospitals in the comp set.

HospitalStateBedsRevenueMargin
EATON RAPIDS MEDICAL CENTER (Target)MI20$34.8M-4.0%
SPECTRUM HEALTH GERBERMI25$116.2M16.0%
ST. FRANCIS HOSPITALMI25$106.2M7.8%
SPECTRUM HEALTH PENNOCK HOSPITMI25$96.5M11.1%
SPECTRUM HEALTH REED CITYMI25$77.1M21.2%
SPARROW EATONMI25$76.1M11.5%
MUNSON HEALTHCARE CHARLEVOIX HMI25$73.6M1.9%
PORTAGE HEALTH SYSTEMMI36$69.3M-16.3%
BRONSON LAKEVIEW HOSPITALMI16$67.9M14.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$730K+210bp18mo
Cost to Collect4.5%2.5%$695K+200bp12mo
Denial Rate Reduction12.0%6.5%$688K+198bp12mo
A/R Days Reduction5200.0%3800.0%$423K+122bp9mo
Clean Claim Rate88.0%96.0%$22K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$730K
Cost to Collect
$695K
Denial Rate Reduction
$688K
A/R Days Reduction
$423K
Clean Claim Rate
$22K
Total EBITDA Uplift$2.6M
Current EBITDA$-1.4M
+ RCM Uplift+$2.6M
Pro Forma EBITDA$1.2M
Current Margin-4.0%
Pro Forma Margin3.3%
WC Released (1x)$1.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.2M$16.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.2M$17.3M0.00x-100.0%
Bull Case9.0x11.0x$-1.9M$25.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.9M$26.7M0.00x-100.0%
Bear Case11.0x10.0x$-2.4M$4.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.4M$3.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 19.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 56.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 52 hospitals with 10-40 beds
  • Same-state prioritization (n=53)
  • Comp margins: P25=-11.2% / P50=0.6% / P75=9.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.